- Friday, May 13, 2022
9:30 AM – 10:30 AM
A Case Based Discussion: Individualizing Localized Prostate Cancer Treatment Decisions with the Oncotype DX® GPS™ Assay
9:30 AM – 10:30 AM
A Case Based Discussion: Individualizing Localized Prostate Cancer Treatment Decisions with the Oncotype DX® GPS™ AssayLocation: S&T Hall: Booth 1043Presenter:
Presenter:
Presenter:
Edward M. Uchio, MD, FACS ### 950526###Presenter#########Presenter:
@@@ Daniel Arthur Shoskes, MD ### 662750###Presenter#########Presenter:
@@@ Steven Canfield, MD ### 535606###Presenter#########Presenter:
12:00 PM – 1:00 PM
Elevate Care in Advanced Prostate Cancer
12:00 PM – 1:00 PM
Elevate Care in Advanced Prostate CancerLocation: S&T Hall: Booth 1043
Kenneth M. Kernen, MD ### 358249###Presenter#########Presenter:
12:30 PM – 1:30 PM
DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
12:30 PM – 1:30 PM
DISCOVER THE IMPACT OF GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB TreatmentLocation: NOENMCC: Great Hall BPresenter: – University of Maryland School of Medicine
Presenter:
Rena D. Malik, MD – University of Maryland School of Medicine ### 1407044###Presenter###Assistant Professor of Surgery###University of Maryland School of Medicine###Presenter: – University of Maryland School of Medicine
@@@ Jeffrey Marc Frankel, MD ### 993964###Presenter#########Presenter:
2:30 PM – 3:30 PM
Cal Ripken, Jr: Battling and Winning the Fight Against Prostate Cancer
with Dr. Ron Tutrone of Chesapeake Urology
2:30 PM – 3:30 PM
Cal Ripken, Jr: Battling and Winning the Fight Against Prostate Cancer with Dr. Ron Tutrone of Chesapeake Urology Location: S&T Hall: Booth 1043Presenter: – Chespaeake Urology Associates
Ronald Francis Tutrone, MD – Chespaeake Urology Associates ### 535847###Presenter###Director of Research###Chespaeake Urology Associates###Presenter: – Chespaeake Urology Associates
- Saturday, May 14, 2022
7:00 AM – 8:00 AM
A Treatment Option for Appropriate Patients With RCC in the Adjuvant Setting
7:00 AM – 8:00 AM
A Treatment Option for Appropriate Patients With RCC in the Adjuvant SettingLocation: NOENMCC: Great Hall BPresenter: – UT Southwestern Dept of Urology
Vitaly Margulis, MD – UT Southwestern Dept of Urology ### 205108###Presenter######UT Southwestern Dept of Urology###Presenter: – UT Southwestern Dept of Urology
### 9:30 AM – 10:30 AM
Experts and ERLEADA®: Hear Other Experts in the Field Discuss New Data for ERLEADA®, A Treatment for Patients with nmCRPC and mCSPC
9:30 AM – 10:30 AM
Experts and ERLEADA®: Hear Other Experts in the Field Discuss New Data for ERLEADA®, A Treatment for Patients with nmCRPC and mCSPCLocation: S&T Hall: Booth 1043Presenter: – Chesapeake Urology Associates. P.A
Presenter:
Presenter: – Duke Health System-Urology Division
Benjamin Hugh Lowentritt, MD – Chesapeake Urology Associates. P.A ### 1407572###Presenter######Chesapeake Urology Associates. P.A###Presenter: – Chesapeake Urology Associates. P.A
@@@ Bryan A. Mehlhaff, MD ### 358248###Presenter#########Presenter:
@@@ Judd W. Moul, MD, FACS – Duke Health System-Urology Division ### 205124###Presenter###James H Semans MD Professor of Surgery###Duke Health System-Urology Division###Presenter: – Duke Health System-Urology Division
12:00 PM – 1:00 PM
Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer
12:00 PM – 1:00 PM
Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer
Location: S&T Hall: Booth 1043
12:30 PM – 1:30 PM
A Treatment Option for Patients with Urothelial Carcinoma in the Adjuvant Setting
12:30 PM – 1:30 PM
A Treatment Option for Patients with Urothelial Carcinoma in the Adjuvant SettingLocation: NOENMCC: Great Hall BPresenter: – UCLA Department of Urology
Karim Chamie, MD – UCLA Department of Urology ### 668667###Presenter######UCLA Department of Urology###Presenter: – UCLA Department of Urology
2:30 PM – 3:30 PM
Ga-PSMA PET: Its Utilization in Urologic Practice -- Moderated by Dr. Sanoj Punnen
2:30 PM – 3:30 PM
Ga-PSMA PET: Its Utilization in Urologic Practice -- Moderated by Dr. Sanoj PunnenLocation: S&T Hall: Booth 1043Presenter:
Presenter: – Urology Associates
Presenter:
Presenter:
Sanoj Punnen, MD ### 358680###Presenter#########Presenter:
@@@ Michael A. Gorin, MD – Urology Associates ### 668200###Presenter###Staff Urologist, Urology Associates & UPMC Western Maryland###Urology Associates###Presenter: – Urology Associates
@@@ Pedro Barata, MD,MSC ### 1610732###Presenter#########Presenter:
@@@ Phillip Koo, MD ### 958956###Presenter#########Presenter:
- Sunday, May 15, 2022
7:00 AM – 8:00 AM
An Oral Treatment Option for Advanced Prostate Cancer
7:00 AM – 8:00 AM
An Oral Treatment Option for Advanced Prostate CancerLocation: NOENMCC: Great Hall B
Ashley E. Ross, MD, PHD ### 667985###Presenter#########Presenter:
9:30 AM – 10:30 AM
PYLARIFY® (piflufolastat F 18) Injection PET/CT Imaging with a Multidisciplinary Expert Panel, A Case Study Review
9:30 AM – 10:30 AM
PYLARIFY® (piflufolastat F 18) Injection PET/CT Imaging with a Multidisciplinary Expert Panel, A Case Study Review Location: S&T Hall: Booth 1043Presenter: – Tulane University Medical School
Presenter: – Massachusetts General Hosptial
Presenter: – Urology Associates
Presenter: – James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT) at the Hoag Family Cancer Institute and Professor of Radiology and Translational Genomics at the University of Southern California
A. Oliver Sartor, MD – Tulane University Medical School ### 205170###Presenter######Tulane University Medical School###Presenter: – Tulane University Medical School
@@@ Jason Efstathiou, MD, PHD – Massachusetts General Hosptial ### 214559###Presenter###Professor###Massachusetts General Hosptial###Presenter: – Massachusetts General Hosptial
@@@ Michael A. Gorin, MD – Urology Associates ### 668200###Presenter###Staff Urologist, Urology Associates & UPMC Western Maryland###Urology Associates###Presenter: – Urology Associates
@@@ Gary Ulaner – James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT) at the Hoag Family Cancer Institute and Professor of Radiology and Translational Genomics at the University of Southern California ### 1613402###Presenter###James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT) at the Hoag Family Cancer Institute and Professor of Radiology and Translational Genomics at the University of Southern California###James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT) at the Hoag Family Cancer Institute and Professor of Radiology and Translational Genomics at the University of Southern California###Presenter: – James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT) at the Hoag Family Cancer Institute and Professor of Radiology and Translational Genomics at the University of Southern California
12:00 PM – 1:00 PM
Chemoablation as primary treatment: Transforming the paradigm for low grade UTUC with JELMYTO
12:00 PM – 1:00 PM
Chemoablation as primary treatment: Transforming the paradigm for low grade UTUC with JELMYTOLocation: S&T Hall: Booth 1043
Jennifer Anne Linehan, MD ### 1407325###Presenter#########Presenter:
12:30 PM – 1:30 PM
Treating Patients with Nocturnal Polyuria: An Expert Panel Discussion
12:30 PM – 1:30 PM
Treating Patients with Nocturnal Polyuria: An Expert Panel DiscussionLocation: NOENMCC: Great Hall BPresenter: – Loyola
Presenter:
Kevin Thomas McVary, MD – Loyola ### 205116###Presenter###Professor###Loyola###Presenter: – Loyola
### @@@ Scott Avard MacDiarmid, MD ### 215277###Presenter#########Presenter:
### 2:30 PM – 3:30 PM
An Individualized Approach to Oral Testosterone Replacement Therapy
2:30 PM – 3:30 PM
An Individualized Approach to Oral Testosterone Replacement TherapyLocation: S&T Hall: Booth 1043Presenter: – Austin Fertility & Reproductive Medicine
Parviz Keikhosrow Kavoussi, MD – Austin Fertility & Reproductive Medicine ### 205069###Presenter###M.D., F.A.C.S.###Austin Fertility & Reproductive Medicine###Presenter: – Austin Fertility & Reproductive Medicine
.jpg)
.jpg)